Zydus Wellness Limited Logo

Zydus Wellness Limited

ZYDUSWELL.NS

(3.2)
Stock Price

1.961,50 INR

0% ROA

5.76% ROE

40.45x PER

Market Cap.

123.048.573.375,00 INR

0% DER

0.26% Yield

12.36% NPM

Zydus Wellness Limited Stock Analysis

Zydus Wellness Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Zydus Wellness Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 Dividend

Investors can trust the company's impressive dividend track record, consistently distributing dividends over the past five years, showcasing a strong commitment to rewarding shareholders.

6 ROE

ROE in an average range (11.91%) suggests satisfactory profitability and decent utilization of shareholders' equity.

7 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

8 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (18.497) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 ROA

The stock's ROA (0%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

Zydus Wellness Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Zydus Wellness Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Zydus Wellness Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Zydus Wellness Limited Revenue
Year Revenue Growth
2006 427.052.000
2007 563.329.000 24.19%
2008 1.947.408.000 71.07%
2009 2.680.700.000 27.35%
2010 3.363.700.000 20.31%
2011 3.314.500.000 -1.48%
2012 3.870.900.000 14.37%
2013 4.027.300.000 3.88%
2014 4.207.600.000 4.29%
2015 4.276.400.000 1.61%
2016 4.273.600.000 -0.07%
2017 5.014.900.000 14.78%
2018 8.082.100.000 37.95%
2019 17.341.900.000 53.4%
2020 18.536.600.000 6.45%
2021 19.884.600.000 6.78%
2022 22.426.100.000 11.33%
2023 17.516.000.000 -28.03%
2023 23.278.000.000 24.75%
2024 33.640.000.000 30.8%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Zydus Wellness Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 10.983.000 100%
2017 190.960.000 94.25%
2018 22.100.000 -764.07%
2019 100.000 -22000%
2020 111.500.000 99.91%
2021 94.600.000 -17.86%
2022 85.000.000 -11.29%
2023 0 0%
2023 48.000.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Zydus Wellness Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 136.808.000
2007 194.719.000 29.74%
2008 833.399.000 76.64%
2009 1.147.000.000 27.34%
2010 1.319.300.000 13.06%
2011 1.376.700.000 4.17%
2012 5.500.000 -24930.91%
2013 78.700.000 93.01%
2014 74.500.000 -5.64%
2015 53.600.000 -38.99%
2016 39.600.000 -35.35%
2017 49.200.000 19.51%
2018 172.700.000 71.51%
2019 130.300.000 -32.54%
2020 506.400.000 74.27%
2021 504.100.000 -0.46%
2022 181.300.000 -178.05%
2023 0 0%
2023 3.891.000.000 100%
2024 5.152.000.000 24.48%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Zydus Wellness Limited EBITDA
Year EBITDA Growth
2006 51.534.000
2007 77.576.000 33.57%
2008 397.491.000 80.48%
2009 731.000.000 45.62%
2010 914.500.000 20.07%
2011 861.000.000 -6.21%
2012 1.121.200.000 23.21%
2013 1.082.700.000 -3.56%
2014 1.269.600.000 14.72%
2015 1.216.500.000 -4.36%
2016 1.305.600.000 6.82%
2017 1.557.800.000 16.19%
2018 1.945.700.000 19.94%
2019 3.258.700.000 40.29%
2020 3.507.200.000 7.09%
2021 3.540.900.000 0.95%
2022 3.420.100.000 -3.53%
2023 836.000.000 -309.1%
2023 3.081.000.000 72.87%
2024 6.208.000.000 50.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Zydus Wellness Limited Gross Profit
Year Gross Profit Growth
2006 177.323.000
2007 256.583.000 30.89%
2008 1.220.138.000 78.97%
2009 1.818.500.000 32.9%
2010 2.161.700.000 15.88%
2011 2.147.600.000 -0.66%
2012 2.610.000.000 17.72%
2013 2.768.900.000 5.74%
2014 2.933.700.000 5.62%
2015 3.049.400.000 3.79%
2016 2.928.200.000 -4.14%
2017 3.385.700.000 13.51%
2018 5.080.200.000 33.35%
2019 9.460.700.000 46.3%
2020 9.983.800.000 5.24%
2021 10.019.400.000 0.36%
2022 10.966.300.000 8.63%
2023 7.868.000.000 -39.38%
2023 9.722.000.000 19.07%
2024 16.128.000.000 39.72%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Zydus Wellness Limited Net Profit
Year Net Profit Growth
2006 23.896.000
2007 45.548.000 47.54%
2008 238.015.000 80.86%
2009 452.700.000 47.42%
2010 594.800.000 23.89%
2011 685.900.000 13.28%
2012 971.100.000 29.37%
2013 964.500.000 -0.68%
2014 1.089.500.000 11.47%
2015 1.016.900.000 -7.14%
2016 1.089.800.000 6.69%
2017 1.339.000.000 18.61%
2018 1.691.400.000 20.83%
2019 1.417.200.000 -19.35%
2020 1.187.300.000 -19.36%
2021 3.088.700.000 61.56%
2022 3.104.000.000 0.49%
2023 236.000.000 -1215.25%
2023 2.669.000.000 91.16%
2024 5.908.000.000 54.82%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Zydus Wellness Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 8
2007 8 12.5%
2008 6 -33.33%
2009 12 45.45%
2010 15 26.67%
2011 17 11.76%
2012 25 29.17%
2013 25 0%
2014 28 11.11%
2015 26 -3.85%
2016 28 3.7%
2017 34 20.59%
2018 40 15%
2019 25 -66.67%
2020 20 -26.32%
2021 49 60.42%
2022 49 0%
2023 4 -1500%
2023 42 92.68%
2024 93 55.43%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Zydus Wellness Limited Free Cashflow
Year Free Cashflow Growth
2006 27.501.000
2007 -142.208.000 119.34%
2008 443.247.000 132.08%
2009 532.400.000 16.75%
2010 281.500.000 -89.13%
2011 508.900.000 44.68%
2012 661.600.000 23.08%
2013 856.300.000 22.74%
2014 651.400.000 -31.46%
2015 861.200.000 24.36%
2016 461.100.000 -86.77%
2017 611.800.000 24.63%
2018 1.323.100.000 53.76%
2019 2.346.200.000 43.61%
2020 2.668.500.000 12.08%
2021 1.614.100.000 -65.32%
2022 467.500.000 -245.26%
2023 0 0%
2023 2.054.000.000 100%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Zydus Wellness Limited Operating Cashflow
Year Operating Cashflow Growth
2006 30.547.000
2007 -28.724.000 206.35%
2008 457.493.000 106.28%
2009 567.800.000 19.43%
2010 451.300.000 -25.81%
2011 592.100.000 23.78%
2012 684.100.000 13.45%
2013 910.900.000 24.9%
2014 692.900.000 -31.46%
2015 898.600.000 22.89%
2016 769.500.000 -16.78%
2017 690.600.000 -11.42%
2018 1.493.800.000 53.77%
2019 2.592.500.000 42.38%
2020 2.865.100.000 9.51%
2021 2.368.500.000 -20.97%
2022 917.100.000 -158.26%
2023 0 0%
2023 2.339.000.000 100%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Zydus Wellness Limited Capital Expenditure
Year Capital Expenditure Growth
2006 3.046.000
2007 113.484.000 97.32%
2008 14.246.000 -696.6%
2009 35.400.000 59.76%
2010 169.800.000 79.15%
2011 83.200.000 -104.09%
2012 22.500.000 -269.78%
2013 54.600.000 58.79%
2014 41.500.000 -31.57%
2015 37.400.000 -10.96%
2016 308.400.000 87.87%
2017 78.800.000 -291.37%
2018 170.700.000 53.84%
2019 246.300.000 30.69%
2020 196.600.000 -25.28%
2021 754.400.000 73.94%
2022 449.600.000 -67.79%
2023 0 0%
2023 285.000.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Zydus Wellness Limited Equity
Year Equity Growth
2006 205.758.000
2007 244.784.000 15.94%
2008 689.778.000 64.51%
2009 1.005.800.000 31.42%
2010 1.418.900.000 29.11%
2011 1.877.900.000 24.44%
2012 2.593.900.000 27.6%
2013 3.302.700.000 21.46%
2014 4.129.000.000 20.01%
2015 4.858.000.000 15.01%
2016 5.783.200.000 16%
2017 7.043.500.000 17.89%
2018 33.862.800.000 79.2%
2019 34.608.300.000 2.15%
2020 45.677.900.000 24.23%
2021 48.440.300.000 5.7%
2022 51.226.500.000 5.44%
2023 52.070.000.000 1.62%
2023 53.575.000.000 2.81%
2024 53.575.000.000 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Zydus Wellness Limited Assets
Year Assets Growth
2006 257.134.000
2007 339.841.000 24.34%
2008 1.132.926.000 70%
2009 1.776.600.000 36.23%
2010 2.069.000.000 14.13%
2011 2.672.500.000 22.58%
2012 3.491.200.000 23.45%
2013 4.248.600.000 17.83%
2014 5.079.100.000 16.35%
2015 5.663.500.000 10.32%
2016 6.868.200.000 17.54%
2017 8.289.300.000 17.14%
2018 54.585.200.000 84.81%
2019 55.896.800.000 2.35%
2020 56.664.300.000 1.35%
2021 56.921.800.000 0.45%
2022 58.330.500.000 2.42%
2023 58.312.000.000 -0.03%
2023 61.484.000.000 5.16%
2024 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Zydus Wellness Limited Liabilities
Year Liabilities Growth
2006 51.376.000
2007 95.057.000 45.95%
2008 443.148.000 78.55%
2009 770.800.000 42.51%
2010 650.100.000 -18.57%
2011 794.600.000 18.19%
2012 897.300.000 11.45%
2013 945.900.000 5.14%
2014 950.100.000 0.44%
2015 805.500.000 -17.95%
2016 1.190.700.000 32.35%
2017 1.245.800.000 4.42%
2018 20.722.400.000 93.99%
2019 21.290.200.000 2.67%
2020 10.986.400.000 -93.79%
2021 8.481.500.000 -29.53%
2022 7.104.000.000 -19.39%
2023 6.242.000.000 -13.81%
2023 7.909.000.000 21.08%
2024 0 0%

Zydus Wellness Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
386.85
Net Income per Share
47.81
Price to Earning Ratio
40.45x
Price To Sales Ratio
5x
POCF Ratio
517.01
PFCF Ratio
517.01
Price to Book Ratio
2.3
EV to Sales
5.13
EV Over EBITDA
35.62
EV to Operating CashFlow
530.29
EV to FreeCashFlow
530.29
Earnings Yield
0.02
FreeCashFlow Yield
0
Market Cap
123,05 Bil.
Enterprise Value
126,21 Bil.
Graham Number
951.65
Graham NetNet
49.66

Income Statement Metrics

Net Income per Share
47.81
Income Quality
0.08
ROE
0.06
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.96
EBT Per Ebit
0.96
Ebit per Revenue
0.13
Effective Tax Rate
0.04

Margins

Sales, General, & Administrative to Revenue
0.1
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.47
Operating Profit Margin
0.13
Pretax Profit Margin
0.13
Net Profit Margin
0.12

Dividends

Dividend Yield
0
Dividend Yield %
0.26
Payout Ratio
0
Dividend Per Share
5

Operating Metrics

Operating Cashflow per Share
3.74
Free CashFlow per Share
3.74
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.06
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
49,66
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
841.95
Interest Debt per Share
3.54
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.89
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
3,16 Bil.
Invested Capital
3160000000
Working Capital
3,16 Bil.
Intangibles to Total Assets
0
Average Receivables
1,42 Bil.
Average Payables
1,81 Bil.
Average Inventory
2338000000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Zydus Wellness Limited Dividends
Year Dividends Growth
2010 3
2011 4 25%
2012 5 20%
2013 6 16.67%
2014 6 0%
2015 6 0%
2016 7 0%
2017 7 0%
2018 8 25%
2019 5 -60%
2020 5 0%
2021 5 0%
2022 5 0%
2023 5 0%
2024 5 0%

Zydus Wellness Limited Profile

About Zydus Wellness Limited

Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon D brand; and Sugarlite, a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and cleansers under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. In addition, it exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is based in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Cadila Healthcare Limited.

CEO
Mr. Tarun G. Arora
Employee
1.008
Address
Zydus Corporate Park
Ahmedabad, 382481

Zydus Wellness Limited Executives & BODs

Zydus Wellness Limited Executives & BODs
# Name Age
1 Mr. Nandish Pradip Joshi
Company Secretary
70
2 Mr. Tarun G. Arora
Chief Executive Officer & Whole Time Director
70
3 Mr. Umesh V. Parikh
Chief Financial Officer
70

Zydus Wellness Limited Competitors

Ipca Laboratories Limited Logo
Ipca Laboratories Limited

IPCALAB.NS

(2.8)
TTK Prestige Limited Logo
TTK Prestige Limited

TTKPRESTIG.NS

(2.8)
Sanofi India Limited Logo
Sanofi India Limited

SANOFI.NS

(2.2)
Whirlpool of India Limited Logo
Whirlpool of India Limited

WHIRLPOOL.NS

(1.8)